0 Bewertungen
ID

21498

Beschreibung

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Concomitant Medications Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Stichworte

Versionen (1)
  1. 25.04.17 25.04.17 -
Hochgeladen am

25. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Genetic Screening For HLA-B*5701 in Patients with HIV Concomitant Medications NCT00340080

    Englisch

    Genetic Screening For HLA-B*5701 Concomitant Medications NCT00340080

    1 Formulare  
    Concomitant Medications
    Beschreibung

    Concomitant Medications

    Alias
    UMLS CUI-1
    C2347852
    Subject Identifier
    Beschreibung

    Subject Identifier

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2348585
    Were any concomitant medications taken by the subject at screening or during the study?
    Beschreibung

    If Yes, record each medication on a separate line using Trade Names where possible.

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2347852
    Drug Name
    Beschreibung

    If Yes, record each medication on a separate line using Trade Names where possible.

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2360065
    UMLS CUI [1,2]
    C2347852
    Start Date
    Beschreibung

    Start Date

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0808070
    UMLS CUI [1,2]
    C2347852
    Taken Prior to Study?
    Beschreibung

    Taken Prior to Study

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2826667
    UMLS CUI [1,2]
    C2347852
    Stop Date
    Beschreibung

    Stop Date

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0806020
    UMLS CUI [1,2]
    C2347852
    Ongoing Medication?
    Beschreibung

    Ongoing Medication

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2826666
    Concomitant Antiretroviral Therapy
    Beschreibung

    Concomitant Antiretroviral Therapy

    Alias
    UMLS CUI-1
    C1963724
    UMLS CUI-2
    C2347852
    Subject Identifier
    Beschreibung

    Subject Identifier

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C2348585
    Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
    Beschreibung

    If Yes, record each medication on a separate line using Trade Names where possible.

    Datentyp

    text

    Alias
    UMLS CUI [1]
    C1963724
    Drug Name
    Beschreibung

    If Yes, record each medication on a separate line using Trade Names where possible.

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2360065
    UMLS CUI [1,2]
    C1963724
    Unit Dose
    Beschreibung

    If Yes, record each medication on a separate line using Trade Names where possible

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0869039
    UMLS CUI [1,2]
    C1963724
    Unit
    Beschreibung

    Unit

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C1519795
    UMLS CUI [1,2]
    C1963724
    Frequency
    Beschreibung

    Frequency

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C3476109
    UMLS CUI [1,2]
    C1963724
    Start Date
    Beschreibung

    Start Date

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0808070
    UMLS CUI [1,2]
    C1963724
    Stop Date
    Beschreibung

    Stop Date

    Datentyp

    date

    Alias
    UMLS CUI [1,1]
    C0806020
    UMLS CUI [1,2]
    C1963724
    Ongoing Medication?
    Beschreibung

    Ongoing Medication

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2826666
    UMLS CUI [1,2]
    C1963724
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Genetic Screening For HLA-B*5701 Concomitant Medications NCT00340080

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Concomitant Medications
    C2347852 (UMLS CUI-1)
    Subject Identifier
    Item
    Subject Identifier
    text
    C2348585 (UMLS CUI [1])
    Item
    Were any concomitant medications taken by the subject at screening or during the study?
    text
    C2347852 (UMLS CUI [1])
    antiretroviral therapy
    Code List
    Were any concomitant medications taken by the subject at screening or during the study?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Drug Name
    Item
    Drug Name
    text
    C2360065 (UMLS CUI [1,1])
    C2347852 (UMLS CUI [1,2])
    Start Date
    Item
    Start Date
    date
    C0808070 (UMLS CUI [1,1])
    C2347852 (UMLS CUI [1,2])
    Item
    Taken Prior to Study?
    text
    C2826667 (UMLS CUI [1,1])
    C2347852 (UMLS CUI [1,2])
    antiretroviral therapy
    Code List
    Taken Prior to Study?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Stop Date
    Item
    Stop Date
    date
    C0806020 (UMLS CUI [1,1])
    C2347852 (UMLS CUI [1,2])
    Item
    Ongoing Medication?
    text
    C2826666 (UMLS CUI [1])
    antiretroviral therapy
    Code List
    Ongoing Medication?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item Group
    Concomitant Antiretroviral Therapy
    C1963724 (UMLS CUI-1)
    C2347852 (UMLS CUI-2)
    Subject Identifier
    Item
    Subject Identifier
    text
    C2348585 (UMLS CUI [1])
    Item
    Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
    text
    C1963724 (UMLS CUI [1])
    antiretroviral therapy
    Code List
    Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Drug Name
    Item
    Drug Name
    text
    C2360065 (UMLS CUI [1,1])
    C1963724 (UMLS CUI [1,2])
    Unit Dose
    Item
    Unit Dose
    text
    C0869039 (UMLS CUI [1,1])
    C1963724 (UMLS CUI [1,2])
    Item
    Unit
    text
    C1519795 (UMLS CUI [1,1])
    C1963724 (UMLS CUI [1,2])
    Unit
    Code List
    Unit
    CL Item
    Tablet  (TAB)
    CL Item
    Microlitre  (MCL)
    CL Item
    Millilitre  (ML)
    CL Item
    Litre  (L)
    CL Item
    Microgram  (MCG)
    CL Item
    Milligram  (MG)
    CL Item
    Gram (G)
    Item
    Frequency
    text
    C3476109 (UMLS CUI [1,1])
    C1963724 (UMLS CUI [1,2])
    Frequency
    Code List
    Frequency
    CL Item
    1 x Daily (OD)
    CL Item
    2 x Daily (BID)
    CL Item
    3 x Daily (TID)
    CL Item
    4 x Daily  (QID)
    CL Item
    As required (PRN)
    Start Date
    Item
    Start Date
    date
    C0808070 (UMLS CUI [1,1])
    C1963724 (UMLS CUI [1,2])
    Stop Date
    Item
    Stop Date
    date
    C0806020 (UMLS CUI [1,1])
    C1963724 (UMLS CUI [1,2])
    Item
    Ongoing Medication?
    text
    C2826666 (UMLS CUI [1,1])
    C1963724 (UMLS CUI [1,2])
    antiretroviral therapy
    Code List
    Ongoing Medication?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video